One person, one family, one community at a time, the Hunter Medical Research Institute (HMRI) fights the illnesses affecting lives throughout the world. Our translational research model aligns over 1500 researchers, students and support staff from Hunter New England Health and the University of Newcastle, inspiring new discoveries to deliver a healthier future.

Throughout Newcastle and the Hunter region researchers, students and support staff are working across six HMRI Research Programs to prevent, cure and treat a diverse range of serious illnesses by translating research findings made in the laboratory into real health treatments and preventative strategies. Internationally-recognised research outcomes are being achieved in asthma and airway diseases, cancer, diabetes, mental health, nutrition, pregnancy and reproduction, stroke and more. Collaborations are being conducted with institutes on all points of the globe.

HMRI provides vital funding and facilities to fuel research, but the heart and soul of the Institute are people – the researchers, the generous donors and supporters, the committed volunteers, and the patients who participate in trials and ultimately benefit from the research results.

Upcoming Events

HCRF Dine for a Dream 2021
HCRF Dine for a Dream 2021
August 20, 2021 - 6:30pm to 11:30pm

Hunter Children's Research Foundation are hosting Dine for a Dream at Noahs on the Beach, Newcastle to raise vital funds for children's research.

Latest News & Articles

May 31 2021

2020 HMRI Award for Mid-Career Researcher Tracy Burrows intends to find out

May 31 2021

Women's health and fertility applications make up nearly 10% of all health-related apps on smartphone app stores. But do they actually work?

May 31 2021

Associate Professor Narelle Eather knows the pressure on teachers to cover the curriculum while keeping kids engaged and active. Before teaching at the University of Newcastle and becoming a HMRI Physical Activity Researcher she taught primary and secondary school students. 

May 20 2021

ImmVirX Pty Ltd has announced the successful completion of $22 million in fundraising, which will go towards the first human studies of its new cancer treatment. ImmVirX is a biotechnology company based at the Hunter Medical Research Institute (HMRI*) and is supported by the University of Newcastle Research Associates (TUNRA).